Illuminating drug discovery with biological pathways

被引:82
|
作者
Apic, G
Ignjatovic, T
Boyer, S
Russell, RB
机构
[1] Cambridge Cell Networks, Cambridge CB3 0FD, England
[2] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[3] EMBL, D-69112 Heidelberg, Germany
关键词
systems biology; drug discovery; biological pathways;
D O I
10.1016/j.febslet.2005.02.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systems biology promises to impact significantly on the drug discovery process. One of its ultimate goals is to provide an understanding of the complete set of molecular mechanisms describing an organism. Although this goal is a long way off, many useful insights can already come from currently available information and technology. One of the biggest challenges in drug discovery today is the high attrition rate: many promising candidates prove ineffective or toxic owing to a poor understanding of the molecular mechanisms of biological systems they target. A "systems" approach can help identify pathways related to a disease and can suggest secondary effects of drugs that might cause these problems and thus ultimately improve the drug discovery pipeline. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1872 / 1877
页数:6
相关论文
共 50 条
  • [31] Illuminating the Reaction Pathways of Viromimetic Assembly
    Cingil, Hande E.
    Boz, Emre B.
    Biondaro, Giovanni
    de Vries, Renko
    Stuart, Martien A. Cohen
    Kraft, Daniela J.
    van der Schoot, Paul
    Sprakel, Joris
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2017, 139 (13) : 4962 - 4968
  • [32] Illuminating the druggable genome: Pathways to progress
    Sharma, Karlie R.
    Colvis, Christine M.
    Rodgers, Griffih P.
    Sheeley, Douglas M.
    DRUG DISCOVERY TODAY, 2024, 29 (03)
  • [33] Biological signaling pathways and potential mathematical network representations: biological discovery through optimization
    Isaza, Clara
    Rosas, Juan F.
    Lorenzo, Enery
    Marrero, Arlette
    Ortiz, Cristina
    Ortiz, Michael R.
    Perez, Lynn
    Cabrera-Rios, Mauricio
    CANCER MEDICINE, 2018, 7 (05): : 1875 - 1895
  • [34] Illuminating and inhibiting carbohydrate biosynthetic pathways
    Kiessling, Laura L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233
  • [35] In vitro Studies of Transendothelial Migration for Biological and Drug Discovery
    Salminen, Alec T.
    Allahyari, Zahra
    Gholizadeh, Shayan
    McCloskey, Molly C.
    Ajalik, Raquel
    Cottle, Renee N.
    Gaborski, Thomas R.
    McGrath, James L.
    FRONTIERS IN MEDICAL TECHNOLOGY, 2020, 2
  • [36] Application of biological target fishing technology in drug discovery
    Ye X.
    Materials Science Forum, 2020, 980 : 210 - 219
  • [37] Solid-Phase Biological Assays for Drug Discovery
    Forsberg, Erica M.
    Sicard, Clemence
    Brennan, John D.
    ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 7, 2014, 7 : 337 - 359
  • [38] Introduction to biological complexity as a missing link in drug discovery
    Gintant, Gary A.
    George, Christopher H.
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (08) : 753 - 763
  • [39] Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery
    de Wet, Timothy J.
    Warner, Digby F.
    Mizrahi, Valerie
    ACCOUNTS OF CHEMICAL RESEARCH, 2019, 52 (08) : 2340 - 2348
  • [40] Drug discovery and the maze of biological complexity: an editorial essay
    Subramaniam, Shankar
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2014, 6 (03) : 225 - 226